ESMC
Escalon Medical Corp.
Price Chart
Latest Quote
$0.18
-0.02 (-10.00%)
Current Price
| Previous Close | $0.20 |
| Open | $0.19 |
| Day High | $0.19 |
| Day Low | $0.18 |
| Volume | 8,913 |
Stock Information
| Shares Outstanding | 7.42M |
| Total Debt | $1.01M |
| Cash Equivalents | $3.34M |
| Revenue | $11.45M |
| Net Income | $915K |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $1.33M |
| P/E Ratio | 1.50 |
| EPS (TTM) | $0.12 |
| Exchange | OQB |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-352K |
| Sales | $11.45M |
| Income | $915K |
| Book/sh | $0.47 |
| Cash/sh | $0.45 |
| Employees | 39 |
Financial Ratios
| Quick Ratio | 1.85 |
| Current Ratio | 2.59 |
| Debt/Eq | 24.37 |
| EPS Growth TTM | 774.30% |
Returns & Margins
| ROA | -8.78% |
| ROE | 57.49% |
| Gross Margin | 41.48% |
| Operating Margin | -16.07% |
| Profit Margin | 16.18% |
Ownership
| Insider Ownership | 1.90% |
| Institutional Ownership | 7.91% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| PEG | 2.07 |
| P/S | 0.12 |
| P/B | 0.38 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.20 |
| SMA50 | $0.19 |
| SMA200 | $0.19 |
| RSI | 33.33 |
| ATR | 0.0064 |
| Shares Float | 7.27M |
| Short Float | 0.03% |
| Short Ratio | 0.31 |
| Rel Volume | 0.93 |
Performance History
| Week | -10.00% |
| Month | -21.74% |
| Quarter | -5.26% |
| 6 Months | +28.57% |
| YTD | +5.88% |
| Year | -30.77% |
| 3 Years | -14.29% |
| 5 Years | -35.71% |
| 10 Years | -74.29% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $0.18 | 13,300 |
| 2026-06-17 | $0.20 | 0 |
| 2026-06-16 | $0.20 | 3,300 |
| 2026-06-15 | $0.20 | 900 |
| 2026-06-12 | $0.20 | 6,300 |
| 2026-06-11 | $0.20 | 17,600 |
| 2026-06-10 | $0.19 | 0 |
| 2026-06-09 | $0.19 | 0 |
| 2026-06-08 | $0.19 | 0 |
| 2026-06-05 | $0.19 | 20,500 |
| 2026-06-04 | $0.21 | 0 |
| 2026-06-03 | $0.21 | 50,600 |
| 2026-06-02 | $0.20 | 0 |
| 2026-06-01 | $0.20 | 15,000 |
| 2026-05-29 | $0.20 | 31,500 |
| 2026-05-28 | $0.21 | 69,800 |
| 2026-05-27 | $0.19 | 1,200 |
| 2026-05-26 | $0.21 | 0 |
| 2026-05-22 | $0.21 | 7,500 |
| 2026-05-21 | $0.21 | 48,200 |
| 2026-05-20 | $0.21 | 61,000 |
| 2026-05-19 | $0.23 | 41,900 |
About Escalon Medical Corp.
Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals for ophthalmic applications in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea. The company also provides Ispan Intraocular Gases, such as C3F8 and SF6 that are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery; and AXIS Image management system for managing ophthalmic diagnostic images through the web browser from various devices. In addition, it markets disposable surgical packs used in vitreoretinal surgery, including packs that aid surgeons in the process of injecting and extracting silicone oil. Further, the company engages in the manufacturing and distribution of patented disposable universal gas kit, which delivers the gas from the canister to the patient. It sells its products to medical institutions through independent sales representatives, network of distributors, and internal sales employees. The company was incorporated in 1987 and is based in Wayne, Pennsylvania.
đ° Latest News
No news articles available at the moment. Check back later for updates on ESMC.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $6,535,090 | $6,835,317 | $6,698,858 | $6,096,169 |
| Cost Of Revenue | $6,535,090 | $6,835,317 | $6,698,858 | $6,096,169 |
| Total Revenue | $12,046,148 | $11,981,509 | $12,180,221 | $10,703,070 |
| Operating Revenue | $12,046,148 | $11,981,509 | $12,180,221 | $10,703,070 |
| Expenses | ||||
| Interest Expense | $22,692 | $20,785 | $21,717 | $18,406 |
| Total Expenses | $11,912,931 | $12,085,985 | $11,701,678 | $11,173,133 |
| Other Income Expense | $-5,000 | - | - | $506,305 |
| Other Non Operating Income Expenses | $-5,000 | - | - | $506,305 |
| Net Non Operating Interest Income Expense | $-22,692 | $-20,785 | $-21,717 | $-18,161 |
| Interest Expense Non Operating | $22,692 | $20,785 | $21,717 | $18,406 |
| Operating Expense | $5,377,841 | $5,250,668 | $5,002,820 | $5,076,964 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $105,525 | $-125,261 | $456,826 | $18,081 |
| Net Interest Income | $-22,692 | $-20,785 | $-21,717 | $-18,161 |
| Normalized Income | $105,525 | $-125,261 | $456,826 | $18,081 |
| Net Income From Continuing And Discontinued Operation | $105,525 | $-125,261 | $456,826 | $18,081 |
| Total Operating Income As Reported | $133,217 | $-104,476 | $478,543 | $-470,063 |
| Net Income Common Stockholders | $28,094 | $-176,933 | $221,531 | $-33,519 |
| Net Income | $105,525 | $-125,261 | $456,826 | $18,081 |
| Net Income Including Noncontrolling Interests | $105,525 | $-125,261 | $456,826 | $18,081 |
| Net Income Continuous Operations | $105,525 | $-125,261 | $456,826 | $18,081 |
| Pretax Income | $105,525 | $-125,261 | $456,826 | $18,081 |
| Operating Income | $133,217 | $-104,476 | $478,543 | $-470,063 |
| Gross Profit | $5,511,058 | $5,146,192 | $5,481,363 | $4,606,901 |
| Interest Income | - | - | $128 | $245 |
| Interest Income Non Operating | - | - | $128 | $245 |
| Special Income Charges | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $0.00 | $-0.02 | $0.03 | $-0.00 |
| Basic EPS | $0.00 | $-0.02 | $0.03 | $-0.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $166,036 | $-58,461 | $523,745 | $84,919 |
| Reconciled Depreciation | $37,819 | $46,015 | $45,202 | $48,432 |
| EBITDA (Bullshit earnings) | $166,036 | $-58,461 | $523,745 | $84,919 |
| EBIT | $128,217 | $-104,476 | $478,543 | $36,487 |
| Diluted Average Shares | $14,252,202 | $7,415,329 | $13,564,202 | $13,220,202 |
| Basic Average Shares | $7,415,329 | $7,415,329 | $7,415,329 | $7,415,329 |
| Diluted NI Availto Com Stockholders | $28,094 | $-176,933 | $221,531 | $-33,519 |
| Preferred Stock Dividends | $77,431 | $51,672 | $235,295 | $51,600 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Research And Development | $753,130 | $688,189 | $818,769 | $990,982 |
| Selling General And Administration | $4,624,711 | $4,562,479 | $4,184,051 | $4,085,982 |
| Total Unusual Items | - | - | - | - |
| Total Unusual Items Excluding Goodwill | - | - | - | - |
| Impairment Of Capital Assets | - | - | - | - |
Fetched: 2026-02-02
Balance Sheet (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $1,885,315 | $1,760,140 | $1,864,857 | $1,395,267 |
| Total Assets | $4,993,059 | $4,757,925 | $5,307,951 | $5,172,237 |
| Total Non Current Assets | $381,122 | $361,097 | $670,484 | $986,455 |
| Other Non Current Assets | $62,788 | $62,788 | $62,787 | $62,788 |
| Goodwill And Other Intangible Assets | $29,792 | $49,442 | $69,986 | $82,750 |
| Other Intangible Assets | $29,792 | $49,442 | $69,986 | $82,750 |
| Current Assets | $4,611,937 | $4,396,828 | $4,637,467 | $4,185,782 |
| Other Current Assets | $164,394 | $194,096 | $249,790 | $190,043 |
| Restricted Cash | $256,550 | $256,422 | $256,293 | $256,165 |
| Inventory | $2,142,263 | $1,613,118 | $1,587,989 | $1,603,955 |
| Receivables | $1,502,895 | $2,124,159 | $1,653,721 | $1,541,750 |
| Accounts Receivable | $1,502,895 | $2,124,159 | $1,653,721 | $1,541,750 |
| Allowance For Doubtful Accounts Receivable | $-164,499 | $-171,104 | $-153,878 | - |
| Gross Accounts Receivable | $1,667,394 | $2,295,263 | $1,807,599 | - |
| Cash Cash Equivalents And Short Term Investments | $545,835 | $209,033 | $889,674 | $593,869 |
| Cash And Cash Equivalents | $545,835 | $209,033 | $889,674 | $593,869 |
| Cash Financial | $545,835 | $209,033 | $889,674 | $593,869 |
| Debt | ||||
| Total Debt | $523,303 | $524,719 | $889,879 | $1,205,040 |
| Long Term Debt And Capital Lease Obligation | $392,704 | $279,404 | $520,049 | $692,222 |
| Long Term Debt | $224,689 | $271,333 | $305,946 | $153,428 |
| Current Debt And Capital Lease Obligation | $130,599 | $245,315 | $369,830 | $512,818 |
| Current Debt | $44,078 | $37,349 | $40,192 | $208,081 |
| Other Current Borrowings | $44,078 | $37,349 | $40,192 | $6,506 |
| Net Debt | - | $99,649 | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $3,077,952 | $2,948,343 | $3,373,108 | $3,694,220 |
| Total Non Current Liabilities Net Minority Interest | $392,704 | $279,404 | $520,049 | $692,222 |
| Current Liabilities | $2,685,248 | $2,668,939 | $2,853,059 | $3,001,998 |
| Other Current Liabilities | $93,727 | $85,692 | $87,125 | $129,961 |
| Current Deferred Liabilities | $327,919 | $280,004 | $426,227 | $332,383 |
| Payables And Accrued Expenses | $1,574,618 | $1,553,462 | $1,466,903 | $1,549,107 |
| Interest Payable | $112,389 | $112,389 | $112,389 | $112,389 |
| Payables | $1,429,144 | $1,398,868 | $1,306,613 | $1,112,831 |
| Total Tax Payable | $41,952 | $41,646 | $101,103 | $100,380 |
| Accounts Payable | $1,387,192 | $1,357,222 | $1,205,510 | $1,012,451 |
| Other Non Current Liabilities | - | - | - | - |
| Non Current Deferred Liabilities | - | - | - | - |
| Non Current Deferred Taxes Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $1,270,107 | $1,164,582 | $1,289,843 | $833,017 |
| Preferred Stock Equity | $645,000 | $645,000 | $645,000 | $645,000 |
| Total Equity Gross Minority Interest | $1,915,107 | $1,809,582 | $1,934,843 | $1,478,017 |
| Stockholders Equity | $1,915,107 | $1,809,582 | $1,934,843 | $1,478,017 |
| Retained Earnings | $-68,439,351 | $-68,544,876 | $-68,419,615 | $-68,876,441 |
| Other | ||||
| Ordinary Shares Number | $7,415,329 | $7,415,329 | $7,415,329 | $7,415,329 |
| Share Issued | $7,415,329 | $7,415,329 | $7,415,329 | $7,415,329 |
| Tangible Book Value | $1,240,315 | $1,115,140 | $1,219,857 | $750,267 |
| Invested Capital | $1,538,874 | $1,473,264 | $1,635,981 | $1,194,526 |
| Working Capital | $1,926,689 | $1,727,889 | $1,784,408 | $1,183,784 |
| Capital Lease Obligations | $254,536 | $216,037 | $543,741 | $843,531 |
| Total Capitalization | $2,139,796 | $2,080,915 | $2,240,789 | $1,631,445 |
| Additional Paid In Capital | $69,702,043 | $69,702,043 | $69,702,043 | $69,702,043 |
| Capital Stock | $652,415 | $652,415 | $652,415 | $652,415 |
| Common Stock | $7,415 | $7,415 | $7,415 | $7,415 |
| Preferred Stock | $645,000 | $645,000 | $645,000 | $645,000 |
| Long Term Capital Lease Obligation | $168,015 | $8,071 | $214,103 | $538,794 |
| Current Deferred Revenue | $327,919 | $280,004 | $426,227 | $332,383 |
| Current Capital Lease Obligation | $86,521 | $207,966 | $329,638 | $304,737 |
| Pensionand Other Post Retirement Benefit Plans Current | $526,307 | $472,388 | $470,896 | $445,651 |
| Current Provisions | $32,078 | $32,078 | $32,078 | $32,078 |
| Current Accrued Expenses | $145,474 | $154,594 | $160,290 | $436,276 |
| Net PPE | $288,542 | $248,867 | $537,711 | $840,917 |
| Accumulated Depreciation | $-954,908 | $-945,986 | $-911,268 | $-885,984 |
| Gross PPE | $1,243,450 | $1,194,853 | $1,448,979 | $1,726,901 |
| Leases | $39,048 | $39,048 | $39,048 | $39,048 |
| Other Properties | $1,075,903 | $1,027,306 | $1,281,432 | $1,559,354 |
| Machinery Furniture Equipment | $128,499 | $128,499 | $128,499 | $128,499 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $925,162 | $558,260 | $880,717 | $805,698 |
| Work In Process | $96,496 | $455,607 | $85,575 | $138,182 |
| Raw Materials | $1,120,605 | $599,251 | $882,093 | $1,010,471 |
| Inventories Adjustments Allowances | - | $-259,743 | $-260,396 | $-350,396 |
| Line Of Credit | - | - | $0 | $201,575 |
Fetched: 2026-02-02
Cash Flow Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $376,845 | $-643,056 | $311,304 | $-1,049,925 |
| Operating Activities | ||||
| Operating Cash Flow | $380,725 | $-602,771 | $325,146 | $-1,049,925 |
| Cash Flow From Continuing Operating Activities | $380,725 | $-602,771 | $325,146 | $-1,049,925 |
| Operating Gains Losses | - | - | - | $-506,305 |
| Investing Activities | ||||
| Capital Expenditure | $-3,880 | $-40,285 | $-13,842 | - |
| Investing Cash Flow | $-3,880 | $-40,285 | $-13,842 | $0 |
| Cash Flow From Continuing Investing Activities | $-3,880 | $-40,285 | $-13,842 | $0 |
| Financing Activities | ||||
| Financing Cash Flow | $-39,915 | $-37,456 | $-15,371 | $-6,931 |
| Cash Flow From Continuing Financing Activities | $-39,915 | $-37,456 | $-15,371 | $-6,931 |
| Other | ||||
| Repayment Of Debt | $-39,915 | $-37,456 | $-15,371 | $-6,931 |
| Interest Paid Supplemental Data | $21,035 | $20,991 | $22,281 | $18,406 |
| End Cash Position | $802,385 | $465,455 | $1,145,967 | $850,034 |
| Beginning Cash Position | $465,455 | $1,145,967 | $850,034 | $1,906,890 |
| Changes In Cash | $336,930 | $-680,512 | $295,933 | $-1,056,856 |
| Net Issuance Payments Of Debt | $-39,915 | $-37,456 | $-15,371 | $-6,931 |
| Net Long Term Debt Issuance | $-39,915 | $-37,456 | $-15,371 | $-6,931 |
| Long Term Debt Payments | $-39,915 | $-37,456 | $-15,371 | $-6,931 |
| Net PPE Purchase And Sale | $-3,880 | $-40,285 | $-6,687 | $0 |
| Purchase Of PPE | $-3,880 | $-40,285 | $-6,687 | $0 |
| Change In Working Capital | $75,633 | $-810,110 | $-644,439 | $-1,045,119 |
| Change In Other Working Capital | $47,915 | $-146,223 | $93,844 | $-31,317 |
| Change In Other Current Liabilities | $-218,621 | $-329,138 | $-347,573 | $-337,273 |
| Change In Other Current Assets | $29,702 | $55,694 | $-59,746 | $-2,684 |
| Change In Payables And Accrued Expense | $75,075 | $88,051 | $-56,959 | $128,699 |
| Change In Accrued Expense | $45,105 | $-63,661 | $-250,018 | $218,373 |
| Change In Payable | $29,970 | $151,712 | $193,059 | $-89,674 |
| Change In Account Payable | $29,970 | $151,712 | $193,059 | $-89,674 |
| Change In Inventory | $-486,307 | $-24,476 | $-44,034 | $-187,229 |
| Change In Receivables | $627,869 | $-454,018 | $-229,971 | $-615,315 |
| Changes In Account Receivables | $627,869 | $-454,018 | $-229,971 | $-615,315 |
| Other Non Cash Items | $211,191 | $303,658 | $289,557 | $279,719 |
| Provisionand Write Offof Assets | $-49,443 | $-17,073 | $178,000 | $155,267 |
| Depreciation Amortization Depletion | $37,819 | $46,015 | $45,202 | $48,432 |
| Depreciation And Amortization | $37,819 | $46,015 | $45,202 | $48,432 |
| Net Income From Continuing Operations | $105,525 | $-125,261 | $456,826 | $18,081 |
| Net Intangibles Purchase And Sale | - | $0 | $-7,155 | $0 |
| Purchase Of Intangibles | - | $0 | $-7,155 | $0 |
| Issuance Of Debt | - | - | - | - |
| Net Short Term Debt Issuance | - | - | - | - |
| Short Term Debt Issuance | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Asset Impairment Charge | - | - | - | - |
| Pension And Employee Benefit Expense | - | - | - | - |
Fetched: 2026-02-02